Atlas Trials

A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis

Clinical trial NCT03698448 · WITHDRAWN

Trial details

NCT number
NCT03698448
Sponsor
AlgiPharma AS
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2021-09-01
Primary completion
2022-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.